782 related articles for article (PubMed ID: 11232362)
21. Liver transplantation at the University of Pittsburgh.
Hughes C; Sturdevant M; Cruz R; Fontes P; Bond G; Soltys K; Sindhi R; Mazariegos G; Humar A
Clin Transpl; 2011; ():177-86. PubMed ID: 22755412
[TBL] [Abstract][Full Text] [Related]
22. Contrast patterns of Cytomegalovirus and Epstein-Barr virus infection in pediatric living-donor liver transplant recipients.
Nafady-Hego H; Elgendy H; Uemoto S
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():75-82. PubMed ID: 25894132
[TBL] [Abstract][Full Text] [Related]
23. Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients.
Ganschow R; Schulz T; Meyer T; Broering DC; Burdelski M
J Pediatr Gastroenterol Nutr; 2004 Feb; 38(2):198-203. PubMed ID: 14734884
[TBL] [Abstract][Full Text] [Related]
24. The Bergamo Kidney Transplant Program.
Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
[TBL] [Abstract][Full Text] [Related]
25. One hundred thirty-two consecutive pediatric liver transplants without hospital mortality: lessons learned and outlook for the future.
Broering DC; Kim JS; Mueller T; Fischer L; Ganschow R; Bicak T; Mueller L; Hillert C; Wilms C; Hinrichs B; Helmke K; Pothmann W; Burdelski M; Rogiers X
Ann Surg; 2004 Dec; 240(6):1002-12; discussion 1012. PubMed ID: 15570206
[TBL] [Abstract][Full Text] [Related]
26. Pediatric liver transplantation.
Tiao GM; Alonso MH; Ryckman FC
Semin Pediatr Surg; 2006 Aug; 15(3):218-27. PubMed ID: 16818143
[TBL] [Abstract][Full Text] [Related]
27. Cumulative experience with pediatric living related liver transplantation.
Colombani PM; Lau H; Prabhakaran K; Maley W; Wise B; Schwarz K; Klein A
J Pediatr Surg; 2000 Jan; 35(1):9-12. PubMed ID: 10646765
[TBL] [Abstract][Full Text] [Related]
28. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.11 Paediatrics (specific problems).
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():55-8. PubMed ID: 12091651
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a north american multicenter registry.
Ng VL; Fecteau A; Shepherd R; Magee J; Bucuvalas J; Alonso E; McDiarmid S; Cohen G; Anand R;
Pediatrics; 2008 Dec; 122(6):e1128-35. PubMed ID: 19047213
[TBL] [Abstract][Full Text] [Related]
30. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
Faust TW
Semin Liver Dis; 2000; 20(4):481-95. PubMed ID: 11200417
[TBL] [Abstract][Full Text] [Related]
31. Operational tolerance: past lessons and future prospects.
Levitsky J
Liver Transpl; 2011 Mar; 17(3):222-32. PubMed ID: 21384504
[TBL] [Abstract][Full Text] [Related]
32. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
33. Outcomes in pediatric solid-organ transplantation.
LaRosa C; Baluarte HJ; Meyers KE
Pediatr Transplant; 2011 Mar; 15(2):128-41. PubMed ID: 21309962
[TBL] [Abstract][Full Text] [Related]
34. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
Sokal EM; Antunes H; Beguin C; Bodeus M; Wallemacq P; de Ville de Goyet J; Reding R; Janssen M; Buts JP; Otte JB
Transplantation; 1997 Nov; 64(10):1438-42. PubMed ID: 9392308
[TBL] [Abstract][Full Text] [Related]
35. [Perspectives in pediatric renal transplantation].
Roussey-Kesler G; Decramer S
Nephrol Ther; 2011 Dec; 7(7):618-21. PubMed ID: 22118793
[TBL] [Abstract][Full Text] [Related]
36. Effective control of Epstein-Barr virus infection following pediatric liver transplantation by monitoring of viral DNA load and lymphocyte surface markers.
Imadome K; Fukuda A; Kawano F; Imai Y; Ichikawa S; Mochizuki M; Shigeta T; Kakiuchi T; Sakamoto S; Kasahara M; Fujiwara S
Pediatr Transplant; 2012 Nov; 16(7):748-57. PubMed ID: 22764883
[TBL] [Abstract][Full Text] [Related]
37. Sirolimus in pediatric liver transplantation: a single-center experience.
Gibelli NE; Tannuri U; Pinho-Apezzato ML; Tannuri AC; Maksoud-Filho JG; Andrade WC; Velhote MC; Santos MM; Ayoub AA; Marques da Silva M
Transplant Proc; 2009 Apr; 41(3):901-3. PubMed ID: 19376384
[TBL] [Abstract][Full Text] [Related]
38. An update on liver transplantation: A critical review.
Neuberger J
J Autoimmun; 2016 Jan; 66():51-9. PubMed ID: 26350881
[TBL] [Abstract][Full Text] [Related]
39. Liver transplantation in children: update 2010.
Kamath BM; Olthoff KM
Pediatr Clin North Am; 2010 Apr; 57(2):401-14, table of contents. PubMed ID: 20371044
[TBL] [Abstract][Full Text] [Related]
40. Progress and outcomes of the first high-volume pediatric liver transplantation program in Saudi Arabia.
Fayyad A; Shagrani M; AlGoufi T; ElSheikh Y; Murray J; Elgohary A; AlSebayel M; Burdelski M; Broering DC
Clin Transpl; 2013; ():77-83. PubMed ID: 25095494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
